Navigation Links
Bronchitol Cystic Fibrosis Dose Trial Results Positive
Date:8/11/2008

itionally, no serious adverse events emerged during the 400 mg treatment period and the adverse event profile was similar across all doses.

People affected by cystic fibrosis typically experience a decline in lung function of 1-2% per year during their life, as measured by FEV1.

Pharmaxis has received Orphan Drug Designation and fast track status from the Food and Drug Administration (FDA) for Bronchitol in cystic fibrosis.

Bronchitol is designed to hydrate the airway surface, improve lung hygiene and promote normal lung clearance. Additional data from this trial will be presented at a forthcoming scientific congress. A European, Pharmaxis sponsored, regulatory Phase III clinical trial, designed to lead to a marketing application for Bronchitol in adults and children with cystic fibrosis is due to report preliminary data early in 2009.

Approximately 75,000 people in the major pharmaceutical markets are affected with cystic fibrosis and no products have been approved to improve lung hydration.

To find out more about Pharmaxis, go to http://www.pharmaxis.com.au .

About the Trial

The following information is provided in accord with the ASX and AusBiotech Code of Best Practice for Reporting by Biotechnology, Medical Device and other Life Sciences Companies.

Name of Trial DPM-CF-202 (a Phase II study with Bronchitol)

Blinding Status Open

Design Crossover, Dose response

Treatment Route Inhalation

Frequency Twice daily

Dose levels 400mg, 240 mg, 120 mg, 40 mg for 2 weeks,

1-2 weeks washout between doses

No of subjects PP population 38

Subject Selection diagnosis of cystic fibrosis (sweat test or

Criteria genotype), of either gender, aged 7 years or


'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmaxis Long-Term Safety Study of Bronchitol Completes
2. Pharmaxis Establishes Named Patient Program for Bronchitol
3. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
4. Promising Cystic Fibrosis Compound on Track for Development
5. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
6. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
7. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
8. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
9. Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting
10. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
11. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)...   InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or ... today announced that its CGuard TM Embolic Prevention System ... Piotr Musialek , at the EuroPCR conference ... . PARADIGM, an investigator-initiated P rospective evaluation ... D revascularization I n symptomatic and increased-risk asymptomatic ...
(Date:5/22/2015)... CITY, Calif. , May 22, 2015 ... pharmaceutical company focused on the development and commercialization of ... pain, today announced that interim chief executive officer ... Healthcare Conference and chief financial officer Tim Morris ... Conference. Details of the two presentations are as follows: ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "Market ... and Europe" report to their offering. ,     ... analysis of the respiratory imaging diagnostics market in ... Europe . The service provides ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... 2011 ERT (NASDAQ: ERT ), ... Officer, is scheduled to present at the 2011 ... on Thursday, June 23, 2011 in Boston. ... the Company,s corporate website at  http://www.ert.com . The ...
... June 17, 2011 Alere Inc. (NYSE: ... the requisite consents for each of its consent solicitations ... of the indentures (together, the "Proposed Modifications") governing its ... 8.625% Senior Subordinated Notes due 2018 (the "8.625% Notes") ...
Cached Medicine Technology:ERT to Present at the 2011 Wells Fargo Securities Healthcare Conference on June 23, 2011 2
(Date:5/23/2015)... 2015 On May 13, Nithyananda Yoga ... youngster's yogic power learned through meditation and initiation at ... Bangalore, India. , Yogamaatha, a nine-year-old girl from North ... profile professionals attending the 2015 Business Advocacy Summit at ... blindfolded. , In a demonstration that lasted three ...
(Date:5/23/2015)... Manufacturers are now required to produce water heaters with ... in the field agree that the regulation is aimed at ... is what miles per gallon is to your car. The ... minimum HSPF score has been raised to 8.2, technology has ... of 12. Indeed, the regulation was welcomed by environmentalist, and ...
(Date:5/22/2015)... Calif. (PRWEB) May 22, 2015 ... technology, communication and capacity are intersecting to create ... across society, the opening speaker at WesternU's 34th ... California Lieut. Gov. Gavin Newsom, a former San ... the keynote speaker at the graduation ceremony for ...
(Date:5/22/2015)... May 22, 2015 Hundreds of ... behalf of individuals who allegedly experienced serious internal ... continue to move forward in the U.S. District ... Pretrial Order dated May 4, 2015, the Court ... and electronically stored information. Among other things, the ...
(Date:5/22/2015)... Topsfield, MA (PRWEB) May 22, 2015 ... Keri Hart, MS/CCC, SLP, RAC-CT, CHHRP-QT, Vice President ... International, “A very important ‘language’ that impacts how ... International, the leader in long term care reimbursement, ... and education programs and talent management, launches a ...
Breaking Medicine News(10 mins):Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3
... Pain Drug Market Will Regain Momentum, According to a ... ... Mass., March 10 Decision Resources, one of the,world,s leading research ... of drugs that have been,newly labeled to treat neuropathic pain, including ...
... market to grow to over $1.4 billion by 2012, according to ... ... Millennium,Research Group,s US Markets for Dental Imaging 2008 report, the benefits,associated ... digital X-rays will fuel sales in the overall market.,Robust sales will ...
... announces the following Webcast:, What: EP MedSystems Webcast, ... http://www.videonewswire.com/event.asp?id=46637 , How: Live over ... address above., Contact: Zakia ... 856-753-8533, If you are unable to participate during the ...
... SHENZHEN, China, March 10 /Xinhua-PRNewswire-FirstCall/ -- China,Nepstar Chain ... Company"), the,largest drugstore chain in China based on the ... report financial results for the,fourth quarter and fiscal year ... 19, 2008., The Company will host a conference ...
... control of ... to averting brain damage, LOUISVILLE, Colo., March 10 ... effective cooling technology-the,non- invasive Arctic Sun(R)-is increasing rapidly. The number ... with the Arctic Sun rose to more than 72 percent ...
... DALLAS, March 10 Affiliated Computer,Services, Inc. (NYSE: ... been awarded a,seven-year, $41 million contract to provide ... Hospital System, a,Dallas-based public hospital system., Under ... comprehensive,infrastructure services, including data center operations, network,monitoring and ...
Cached Medicine News:Health News:Newly Labeled Therapies for Neuropathic Pain, Including Drugs From Pfizer and Eli Lilly, Will Drive Growth in the Chronic Pain Drug Market 2Health News:Advanced Technology in Dental Imaging Benefits Patients 2Health News:Advanced Technology in Dental Imaging Benefits Patients 3Health News:Webcast Alert: EP MedSystems Announces EP MedSystems Fourth Quarter 2007 Earnings Conference Call Webcast 2Health News:China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19 2Health News:China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19 3Health News:More than Seventy Percent of Top US Hospitals Control Patient Temperature with High-Tech Arctic Sun(TM) 2Health News:ACS Awarded $41 Million Contract to Provide IT Outsourcing Services to Parkland Hospital 2Health News:ACS Awarded $41 Million Contract to Provide IT Outsourcing Services to Parkland Hospital 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: